JPRN-UMIN000027799尚未招募4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese Patients - Ranibizumab for Exudative Age-Related Macular Degeneration
Akita University Department of Ophthalmology0 个研究点目标入组 50 人开始时间: 2017年6月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) previous treatment for AMD 2) polypoidal choroidal vasculopathy 3) retinal angiomatous proliferation 4) diabetic maculopathy, retinal vascular occlusion, or idiopathic macular telangiectasia
研究者
相似试验
进行中（未招募）
1 期
Intravitreal ranibizumab in patients with retinal pigment epithelial detachments secondary to AMDEUCTR2008-004675-22-DEniversity of Bonn20
已完成
不适用
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularizationeovascular age-related macular degenerationJPRN-UMIN000017081Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences20
已完成
4 期
A multicentre,open-label,prospective,observational study to evaluate effectiveness and safety of repeated intravitreal injections of Lucentis® in patients with wet age-related macular degeneration over a 12-month observational period in a real-world settingCTRI/2013/08/003933ovartis India Limited3,000
已完成
不适用
ong-term Outcome of Intravitreal Ranibizumab Treatment, Compared with Photodynamic Therapy, in Patients with Polypoidal Choroidal Vasculopathypolypoidal choroidal vasculopathyJPRN-UMIN000008630Yokohama City University Medical Center80
进行中（未招募）
1 期
Injections into the eye (drug Lucentis) in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macula associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersEUCTR2013-000031-27-GBMoorfields Eye Hospital80